Rapid-Cycle Re-Implementation of TRAining Facilities in Norway
NCT ID: NCT04406909
Last Updated: 2020-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
4000 participants
INTERVENTIONAL
2020-05-22
2022-05-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Members of training facilities in Norway age 18 to 64 years without COVID-19 related comorbidity will after informed consent be randomised to either access to training or no access in a first 2-week cycle. Testing for COVID-19 and ascertainment of clinical disease will be performed after the first cycle. If there is no clinically meaningful difference between the arms, new cycles may be implemented subsequently, e.g. with less distancing restrictions or wider age groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Intensity and Moderate Training and Maximal Oxygen Uptake and Activity Levels
NCT01931124
Interval Training in Young Healthy Individuals
NCT00733941
Effect of Home-based Training Program for Kidney Transplant Recipients (HOMETRAIN-KTR)
NCT06379009
Physical Activity, Function and Quality of Life in Patients After Endovascular Treatment
NCT01109732
Effective Training in Overweight and Obese People
NCT00218920
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training
Access to training at membership training facility
Access to training facility
Access to training facility under national regulations for COVID control
No training
No access to training at membership training facility
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Access to training facility
Access to training facility under national regulations for COVID control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* plan to use the training facility regularly during the project period
* are willing to adhere to training policies during the project
* accept assessment of project endpoints
* approve handling of data for the project
Exclusion Criteria
* Age below 18 years or above 64 years
18 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Department of Health and Social Affairs
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Bretthauer
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Magnus Løberg, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University of Oslo
Mette Kalager, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University of Oslo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SATS Training
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Helsingen LM, Loberg M, Refsum E, Gjostein DK, Wieszczy P, Olsvik O, Juul FE, Barua I, Jodal HC, Herfindal M, Mori Y, Jore S, Lund-Johansen F, Fretheim A, Bretthauer M, Kalager M; TRAiN study group. Covid-19 transmission in fitness centers in Norway - a randomized trial. BMC Public Health. 2021 Nov 16;21(1):2103. doi: 10.1186/s12889-021-12073-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REK 143984
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.